FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

CAMPBELL VICTOR L 		2. Issuer Name and Ticker or Trading Symbol

HCA Healthcare, Inc. [ HCA ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
SVP
(Last)          (First)          (Middle)

ONE PARK PLAZA 		3. Date of Earliest Transaction (MM/DD/YYYY)

2/13/2018
(Street)

NASHVILLE, TN 37203
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   2/13/2018     M    5664   A $5.9821   138539   D    
Common Stock   2/13/2018     M    6756   A $6.4772   145295   D    
Common Stock   2/13/2018     M    2252   A $10.9168   147547   D    
Common Stock   2/13/2018     M    2252   A $15.9112   149799   D    
Common Stock   2/13/2018     M    75000   A $22.95   224799   D    
Common Stock   2/13/2018     F    44535   D $98.92   180264   D    
Common Stock                  26478   I   By AWC 2012 Trust (Spouse, Trustee)  
Common Stock                  42478   I   By MNC 2012 Trust (Spouse, Trustee)  
Common Stock                  33196   I   By Trust f/b/o AWC (Spouse, Trustee)  
Common Stock                  33196   I   By Trust f/b/o MNC (Spouse, Trustee)  
Common Stock                  65629   I   By Trust (Daughter, Trustee)  

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Non-Qualified Stock Option (right to buy)   $5.9821   (1) 2/13/2018     M         1158      (2) 8/27/2019   Common Stock   1158   (3) $0.00   0   D    
Non-Qualified Stock Option (right to buy)   $5.9821   (1) 2/13/2018     M         4506      (4) 8/27/2019   Common Stock   4506   (3) $0.00   0   D    
Non-Qualified Stock Option (right to buy)   $6.4772   (1) 2/13/2018     M         2252    8/27/2011   8/27/2019   Common Stock   2252   (3) $0.00   0   D    
Non-Qualified Stock Option (right to buy)   $6.4772   (1) 2/13/2018     M         4504      (5) 8/27/2019   Common Stock   4504   (3) $0.00   0   D    
Non-Qualified Stock Option (right to buy)   $10.9168   (1) 2/13/2018     M         2252    8/27/2010   8/27/2019   Common Stock   2252   (3) $0.00   0   D    
Non-Qualified Stock Option (right to buy)   $15.9112   (1) 2/13/2018     M         2252      (6) 8/27/2019   Common Stock   2252   (3) $0.00   0   D    
Stock Appreciation Right   $22.95   2/13/2018     M         37500      (7) 2/8/2022   Common Stock   37500   $0.00   0   D    
Stock Appreciation Right   $22.95   2/13/2018     M         37500      (8) 2/8/2022   Common Stock   37500   $0.00   0   D    

Explanation of Responses:
(1)  Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.
(2)  The option was scheduled to vest in three equal annual installments beginning on August 27, 2012. A change in control of the Issuer occurred effective November 1, 2013, resulting in the accelerated vesting of the option as to the shares that remained unvested.
(3)  Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.
(4)  The option vested in equal increments (i) at the end of fiscal year 2012 upon the achievement of certain annual EBITDA performance targets and (ii) upon a change in control (as defined in the 2006 Stock Incentive Plan for Key Employees of HCA Holdings, Inc. and its Affiliates as Amended and Restated) of the Issuer which occurred effective November 1, 2013.
(5)  The option vested at the end of fiscal years 2010 and 2011 based upon the achievement of certain annual EBITDA performance targets.
(6)  The option vested at the end of fiscal year 2009 based upon the achievement of certain annual EBITDA performance targets.
(7)  The stock appreciation rights vested in four equal annual installments beginning on February 8, 2013.
(8)  The stock appreciation rights vested at the end of fiscal years 2012, 2013, 2014 and 2015 based upon the achievement of certain annual EBITDA performance targets.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
CAMPBELL VICTOR L
ONE PARK PLAZA
NASHVILLE, TN 37203

SVP

Signatures
/s/ Natalie Harrison Cline, Attorney-in-Fact 2/15/2018
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
HCA Healthcare (NYSE:HCA)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more HCA Healthcare Charts.
HCA Healthcare (NYSE:HCA)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more HCA Healthcare Charts.